• Luminal Gastroenterology
• 31 min
  1. Novel treatments for GI malignancies

  • Prof. Bert H. O'Neil
• 40 min
  2. The spectrum of GERD implications for assessment and management

  • Prof. Eamonn M. M. Quigley
• 54 min
  3. Oro-pharyngeal and esophageal motility and dysmotility

  • Dr. John E. Pandolfino
• 55 min
  4. Eosinophilic esophagitis and other non-reflux esophageal disorders

  • Prof. David Katzka
• 39 min
  5. Disorders of gastric function: gastroparesis and functional dyspepsia 1

  • Dr. Braden Kuo
• 17 min
  6. Disorders of gastric function: gastroparesis and functional dyspepsia 2

  • Dr. Braden Kuo
• 48 min
  7. Acid-peptic diseases of the stomach and duodenum including Helicobacter pylori and NSAIDs

  • Prof. Sheila Crowe
• 48 min
  8. Gastric cancer, gastritis and the role of H. pylori

  • Prof. Anthony Axon
• 48 min
  9. Celiac disease

  • Prof. Ciaran Kelly
• 43 min
  10. IBD for the non-gastroenterologist

  • Prof. Sunanda Kane
• 34 min
  11. The enteric microbiota in health and disease

  • Dr. Francisco Guarner
• 45 min
  12. Colorectal cancer and hereditary colon cancer syndromes

  • Prof. Carol A. Burke
• 39 min
  13. The spectrum of GI ischemia 1

  • Prof. Lawrence J. Brandt
• 31 min
  14. The spectrum of Gl ischemia 2

  • Prof. Lawrence J. Brandt
• 41 min
  15. Constipation and defecation disorders

  • Prof. Satish S. C. Rao
• 40 min
  16. Diverticular disease of the colon

  • Dr. Dale Vimalachandran
• 73 min
  17. Irritable bowel syndrome (IBS)

  • Prof. Eamonn M. M. Quigley
• 27 min
  18. Evidence-based management of non-variceal upper GI bleeding

  • Prof. Joseph J. Sung
• Hepatology
• 32 min
  19. Hepatitis B virus (HBV)

  • Prof. Marco Olivera-Martinez
• 26 min
  20. Hepatitis C - cure of infection

  • Prof. Mark Mailliard
• 46 min
  21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI

  • Prof. James H. Lewis
• 26 min
  22. Drug-induced liver injury: risk factors and drug development in DILI

  • Prof. James H. Lewis
• 39 min
  23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI

  • Prof. James H. Lewis
• 22 min
  24. Portal hypertension

  • Prof. John Reinus
• 55 min
  25. Portal hypertension: at the bedside

  • Dr. Clara Y. Tow
• 29 min
  26. The management of chronic liver disease, including transplantation 1

  • Prof. Timothy M. McCashland
• 21 min
  27. The management of chronic liver disease, including transplantation 2

  • Prof. Timothy M. McCashland
• 34 min
  28. Hereditary hemochromatosis: what have we learnt from population studies

  • Prof. John K. Olynyk
• 38 min
  29. Immune-mediated liver disease

  • Dr. Jenny Heathcote
• 51 min
  30. Alcoholic liver disease

  • Prof. Michael Lucey
• The Pancreas and Biliary Tree
• 46 min
  31. Acute pancreatitis

  • Prof. Davor Štimac
• 49 min
  32. Chronic pancreatitis

  • Prof. Christopher Forsmark
• 47 min
  33. Pancreatic cancer

  • Prof. Randall Brand
• 20 min
  34. The management of gallstones in relation to laparoscopic cholecystectomy and gallbladder dyskinesia

  • Prof. John Baillie
• Archived Lectures *These may not cover the latest advances in the field
• 52 min
  35. The management of other aspects of chronic liver disease, including transplantation

  • Prof. Timothy M. McCashland
• 38 min
  36. Chronic viral hepatitis B and C

  • Prof. Mark Mailliard
• 41 min
  37. Pancreatic cancer

  • Prof. Randall Brand
• 72 min
  38. Acute viral hepatitis

  • Prof. Geoffrey Dusheiko
• 33 min
  39. Diverticular disease

  • Dr. Charles Knowles
• 57 min
  40. The spectrum of gastrointestinal ischemia: 2010

  • Prof. Lawrence J. Brandt
• 51 min
  41. Acute pancreatitis

  • Prof. Davor Štimac

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Key concepts
3. Glossary of terms
4. Alcohol-associated mortality
5. Alcohol-related liver deaths in the UK
6. Price of alcohol to income ratio & consumption
7. Consequences of excess alcohol consumption
8. Alcoholism is a clandestine disorder
9. Subjects with alcohol dependence
10. CAGE questions
11. Factors of development of alcoholic liver disease
12. Histology of alcoholic liver disease
13. The mechanism of alcoholic liver disease
14. How strong is the urge to drink alcohol?
15. Divert study
16. Does abstinence matter?
17. Survival and alcohol use vs. abstinence
18. Psychotherapy for alcoholism
19. Pharmacotherapy of alcoholism
20. Pharmacotherapy for alcoholic hepatitis (1)
21. Survival in three randomized controlled trials
22. Pharmacotherapy for alcoholic hepatitis (2)
23. Pentoxifylline improves short-term survival
24. Infliximab in severe alcoholic hepatitis
25. Etanercept and alcoholic hepatitis
26. Liver transplantation in severe alcoholic hepatitis
27. Pharmacotherapy for alcoholic fibrosis/cirrhosis
28. Decompensated alcoholic liver disease
29. Survival after liver transplantation
30. Prognostic factors for increased risk of relapse
31. Does relapse matter?
32. Consequences of relapse after transplantation
33. Key concepts - summary

Topics Covered

• Alcoholism, including the toll of alcoholism, is key to understanding alcoholic liver disease (ALD)
• Alcoholism is clandestine disorder
• Abstinence is key to recovery from both alcoholism and ALD
• There are few evidence-based therapies for ALD, other than abstinence
• Liver transplantation is valuable in selected subjects with ALD

Links

Series:

• Gastroenterology and Hepatology

Categories:

• Clinical Practice
• Metabolism & Nutrition

Therapeutic Areas:

• Gastroenterology & Nephrology

Talk Citation

Publication History

• Published on January 5, 2011

Financial Disclosures

• Prof. Michael Lucey has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.